NXTM : Summary for NxStage Medical, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 30 mins

Nxstage Medical, Inc. (NXTM)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.49-1.52 (-5.43%)
As of 2:30PM EST. Market open.
People also watch
PODDOFIXNUVAATRCWMGI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close28.01
Open27.91
Bid26.65 x 100
Ask26.66 x 400
Day's Range26.48 - 27.91
52 Week Range13.49 - 28.36
Volume561,525
Avg. Volume400,946
Market Cap1.72B
Beta0.17
PE Ratio (TTM)-291.10
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube53 minutes ago

    ETFs with exposure to NxStage Medical, Inc. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to NxStage Medical, Inc. Here are 5 ETFs with the largest exposure to NXTM-US. Comparing the performance and risk of NxStage Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire3 days ago

    NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results

    LAWRENCE, Mass., Jan. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial ...

  • Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
    Zacks15 days ago

    Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay

    Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.